Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports - United Kingdom
doi 10.1038/srep24310
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adverse Prognostic Impact of Perioperative Allogeneic Transfusion on Patients With Stage II/III Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2015English

Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study

Journal of Surgical Research
Surgery
2020English

Prognostic Impact of CDX2 in Stage II Colon Cancer: Results From Two Nationwide Cohorts

British Journal of Cancer
Cancer ResearchOncology
2018English

Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer

Oncotarget
Oncology
2017English

Expression of Aquaporin-1 Is a Poor Prognostic Factor for Stage II and III Colon Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy

Scripta Scientifica Medica
2015English

Use of a Multigene Prognostic Assay for Selection of Adjuvant Chemotherapy in Patients With Stage II Colon Cancer: Impact on Quality-Adjusted Life Expectancy and Costs.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

The Prognostic Value of microRNA-126 and Microvessel Density in Patients With Stage II Colon Cancer: Results From a Population Cohort

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients With Stage II/III Colorectal Cancer

Cancers
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy